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Abstract:
Background:
Demographic  dynamics  and  decreasing  trends  in  mortality  from chronic  diseases  are  major  contributors  to  the  phenomenon  of
population aging. The purpose of the present study was to examine the association between cardiovascular disease (CVD) mortality
and demographic indicators, in Greece the past 60 years.
Methods:
Life Expectancy at birth (LE), population age structure, fertility rates (TFR) and all-cause, CVD mortality rates were retrieved (data
provided  by  the  Hellenic  Statistical  Authority,  1956-2015).  In  order  to  test  the  research  hypothesis  time-series  analysis  was
conducted.
Results:
Increasing trends in LE and in the older age (>65 or >80 years) groups’ share and declining trends in TFR were recorded. CVD
mortality, after an upward course, showed decreasing trends during 1988–2009, accounting for the 96% and 97% increment in LE in
men and women respectively. However, newer records (2010-2015) show a new upward trend. The declining trends in TFR were
highly associated with the shifts towards the upper part of the population age pyramid.
Conclusion:
Population  aging  is  a  historically  unprecedented  event  that  cannot  be  avoided,  deterred  or  alleviated.  Its  negative  effects  act
cumulatively with the recent increases in cardiovascular mortality, especially in the light of the ongoing economic crisis which is
expected to further exacerbate the existing contrasts. A possible way to successfully cope with the new demographic realities is to
unlock an, up till now largely overlooked, opportunity named “healthy aging”.
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1. INTRODUCTION
Recent trends in cardiovascular disease (CVD) mortality show remarkable declining rates in European countries and
North America [1]. Despite this evidence, CVD is still the number one cause of death in most OECD (Organisation for
Economic Co-operation and Development)  countries,  accounting for  more than one-third of  all  deaths  in  2015 [2].
Furthermore, the prevalence of common CVD risk factors like hypertension, obesity, hypercholesterolemia and diabetes
have increased [3, 4], especially in younger people [1], implying that cardiometabolic co-morbidity does not necessarily
follow mortality trends. Furthermore, since cardiovascular health seems to be highly associated with socioeconomic
factors5 and the reduction in CVD mortality over the past years has not been felt equally in all sectors of society - the
most impressive improvements in cardiovascular health benefited the richest societal groups and countries [5] - the
investigation of the most current CVD mortality trends (i.e. under the context of the ongoing economic crisis) is of
particular value.
Alongside, during the last decades, substantial demographic changes have been recorded. Globally, life expectancy
at  birth has increased by approximately 25 years  since the 1950s [6],  probably due to the declining mortality  rates
attributed mainly to the spectacular improvements in health care, in pharmacological and other treatment and in general
to the advances in medical science. The increment in life expectancy, while undeniably a major achievement, coupled
with falling fertility rates, reshapes population pyramids and shifts volumes towards older age groups, a phenomenon
widely  known  as  population  aging.  Europe  is  by  all  means  the  oldest  region  of  the  planet.  Currently,  half  of  the
European population is over 42 years of age, while 1 out of 4 Europeans is above 60 years of age [7].
Of all areas, health care is particularly sensitive to a population's age-structure. Increasing shares of elder and old
age groups are expected to affect: (i) the demand, (ii) the organization and delivery, and, (iii) the cost of health care
systems. In parallel, in the context of the economic crisis, the increased cost of health care for the elderly creates the
risk of raising ethical issues concerning rationing in Medicine (the allocation of scarce resources) [8]. Moreover, as
longevity allows greater number of persons to reach higher ages, previously uncommon conditions become frequent, if
not dominant morbidity causes. Particularly, CVD risk levels increase with age since the key risk factors are either
directly age-related - like hypertension, diabetes, elevated cholesterol levels - or have a cumulative harmful effect, like
tobacco use,  obesity  and physical  inactivity  [9].  Against  this  challenging demographic  background and taking into
account that age is one of the most dominant determinants of cardiovascular health, CVDs are expected to remain the
leading cause of death in the years to come.
In the context of the aforementioned considerations, this paper aims to examine the effect of the trends in CVD
mortality on longevity and on population age structure in Greece, during 1956 – 2015 and to discuss the implications
and challenges arising from this favorable, but, also complex phenomenon involving the modern western world.
2. METHODS
2.1. Official Statistics
Demographic  indicators,  such  as  life  expectancy  at  birth  (LE),  fertility  rates  (TFR),  population  age  structure
(1960-2015) and all-cause, CVD mortality rates (1956-2015) have been calculated using data provided by the Hellenic
Statistical  Authority  (EL.STAT.)  [10]  and  the  EUROSTAT  (Directorate-General  of  the  European  Commission)
Population  Projections-Baseline  scenario  [10  -  13].
2.2. Statistical Analysis
Mortality rates were presented per 100,000 persons. Time trends in the demographic indices and in mortality rates
were graphically presented (Figs. 1 and 2 respectively). Time-series analysis was conducted to evaluate the effect of all-
cause and CVD mortality and fertility trends during 1956-2015 (independent determinants) on life expectancy and on
the  age  structure  of  the  Greek  population  (outcomes),  in  men  and  women  separately.  Due  to  the  presence  of  a
significant interaction between time and the independent variables, a stratified by year analysis was implemented. The
estimated b-coefficients along with the 95% confidence intervals, the corresponding p-values and the adjusted R2 were
provided. All reported p-values were based on two-sided tests and overall statistical significance level was set at 5%.
STATA software, version 14 (MP & Associates, Sparta, Greece) was used for all statistical analyses.
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Fig. (1). Demographic time trends in Greece (1956–2015); source: Hellenic Statistics Authority [10].
Fig. (2). Mortality time trends in Greece (1956–2015); source: Hellenic Statistics Authority.
CVD: cardiovascular disease; CHD: coronary heart disease. Mortality rates were calculated per 100,000 persons [10].
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3. RESULTS
3.1. Population Aging in Greece
According to the latest official statistics (population estimates 2015), the median age of the Greek population has
increased by approximately 10 years since 1970s (i.e. from 32.3 to 43.4 years), and it is expected to further increase in
the future (Table 1). According to the projections provided by EUROSTAT (baseline scenario) [11] by 2030, half of the
Greek population will be over 50 years age; more than one-third will be above 65 years and almost 9% will be above 80
years, in contrast to the youngest population segment which will be limited to just 11% (Table 1). In particular, the
group aged 0-14 comprise a rapidly shrinking part of the Greek population; already <20% in the 1990s, their share
dropped down to as low as 14.5% in 2015. At the other end of the age spectrum, those above 65 years old currently
represent 27% of total population, which is 31% higher than in 2000. The growth rate of those above 80 years old is
even  more  spectacular,  as  their  share  more  than  doubled  since  the  1990s  (Table  1).  The  time  trends  of  the  Greek
population age structure during the last 60 years are presented in Fig. (1).
Table 1. Population age distribution for the Greek population, during the years 1970–2030.
Year 1970 1980 1990 2000 2015 2030a
Total Population, N 8,300,399 8,780,514 9,584,184 10,120,892 10,775,627 9,944,658
<15 years old (%) 24.2 23.1 19.5 14.7 14.5 11.7
65 – 80 years old (%) 11.1 13.1 13.7 17.3 20.9 27.2
>80 years old (%) 2.0 2.3 3.0 3.5 6.3 8.7
Median age (years) 32 34 36 38 43 50
a EUROSTAT Population Projections according to baseline scenario [11].
3.2. Life Expectancy and fertility Trends
The time trends of life expectancy at birth are similar for both men and women and exhibit a linearly increasing
course with men having consistently, approximately 3 years shorter estimates (Fig. 1). In 2015, life expectancy was
increased by 13 years for women and by 11 years for men compared with 1960 with an increasing rate of 0.20 [95%
confidence intervals (CIs): 0.20-0.21), p<0.001] and 0.17 (95% CIs: 0.16-0.17, p<0.001) per year, respectively. Using
the National Vital Statistics for the years 2000-2015 as provided by EL.STAT [10], the highest life expectancy gain was
observed for the 60 to 79 years old men and women, followed by the over 80 years old people (data not shown).
In contrast, the fertility rate in Greece has substantially decreased during the past decades. After a relatively constant
course until the late 1970s, a downward trend followed (Fig. 1) with a declining rate of 0.2 units per decade (p<0.001).
3.3. Mortality Trends
Until the late 1980s, CVD and coronary heart disease (CHD) mortality rates were following an increasing course
(especially for men) (Fig. 2). The peak of CVD death rate for men was in 1987 (570 deaths per 100,000 persons) (i.e.,
257 CHD deaths per 100,000 persons, 137 stroke deaths plus other forms of cardiovascular diseases). CVD and CHD
death rates for women were essentially stable until the early or mid-80s. From 1988 to 2009, this course was reversed
with an annual decreasing rate of 9 deaths for both genders (95% CIs: 8.3-10 for men and 8.0-9.2 for women). A new
upward course of 13 and 18 deaths annually (per 100,000 persons) for men and women respectively (p<0.001) was
recorded during the most recent years (2010-2015). In both genders CHD mortality time trends in Greece over the last
60 years followed the same course as CVD. Stroke deaths were relatively stable until 1970s, followed by a considerable
decline until 2009 and a sharp increase afterwards (2010-2015) for both men and women (Fig. 2). The time trends for
all-cause mortality rate differed, since a stable decreasing course was observed from the 1950s and onwards for both
genders (Fig. 2), with an annual decrement of 11 deaths per 100,000 persons for men (95% CIs: 10-11, p<0.001) and 12
deaths for women (95% CIs: 11-12, p<0.001).
3.4. Effects of Mortality and Fertility Time trends on Life Expectancy and Population Aging
Time  series  analysis  showed  that,  for  men,  CVD and  CHD mortality  rates  were  positively  associated  with  life
expectancy at birth until 1987. During 1988-2009 this association was reversed with the reduction in CVD mortality
accounting for  the 96% in life  expectancy rise for  men and 97% for  women (Table 2).  The decrement  in all-cause
mortality rate since the 1950s was associated with an annual increase in life expectancy by approximately 0.15 years
(p<0.001)  for  both  genders  and  with  a  substantial  growth  in  the  relative  representation  of  the  older  age-groups
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compared with the younger ones (Table 2). Furthermore, from the early 1970s and onwards, the decrement in fertility
rate accounted for the 79% of the 0-15 years age-group shrinkage and for the 43% of the increase in the ratio 65+ to
15-65 years (p<0.001 in both cases).
Table 2. Time-series analysis results that evaluate the effects of mortality and fertility (1956–2015) (independent variables) on
life expectancy and population ageing (dependent variables).
– Gender Time
Life Expectancy
(in years)
Population Age Distribution
65+ years / 15–65 years rate Percent of 0–15 years
b (95% CI) p R2 b (95% CI) p R2 b (95% CI) p R2
CVDa Mortality
(per 10
deaths/100.00
people)
Men
1956–1987 0.31 (0.26, 0.36) <0.001 0.85 0.01 (0.004, 0.01) <0.001 0.76 -0.29 (-0.37, -0.21) <0.001 0.68
1988–2009 -0.16 (-0.17, -0.14) <0.001 0.96 -0.01 (-0.005, -0.004) <0.001 0.97 0.31 (0.26, 0.36) <0.001 0.89
2010–2015 0.14 (0.05, 0.22) 0.011 0.79 0.01 (0.004, 0.01) 0.001 0.92 -0.01 (-0.04, 0.02) 0.420 0.17
Women
1956–1987 -0.68 (-1.0, -0.35) <0.001 0.39 -0.01 (-0.02, -0.01) <0.001 0.64 0.67 (0.44, 0.89) <0.001 0.57
1988–2009 -0.22 (-0.24, -0.20) <0.001 0.97 -0.01 (-0.01, -0.005) <0.001 0.97 0.34 (0.29, 0.39) <0.001 0.92
2010–2015 0.07 (0.01, 0.13) 0.036 0.64 0.004 (0.001, 0.01) 0.009 0.82 -0.01 (-0.02, 0.01) 0.459 0.14
All-cause
Mortality
(per 10
deaths/100.00
people)
Men 1956–2015 -0.14 (-0.15, -0.13) <0.001 0.92 -0.003 (-0.003, -0.002) <0.001 0.90 0.22 (0.21, 0.23) <0.001 0.96
Women 1956–2015 -0.16 (-0.17, -0.15) <0.001 0.95 -0.003 (-0.003, -0.002) <0.001 0.91 0.21 (0.20, 0.22) <0.001 0.97
Fertility Rate
(per 1 unit/woman)
All
1956–1970 3.7 (0.25, 7.2) 0.039 0.36 0.11 (0.01, 0.21) 0.041 0.32 -4.6 (-11, 1.8) 0.141 0.14
1971–2015 -4.6 (-5.5, -3.7) <0.001 0.69 -0.07 (-0.09, -0.04) <0.001 0.43 8.2 (6.9, 9.5) <0.001 0.79
a CVD: cardiovascular disease. Regression b-coefficients illustrate the effect of CVD or all-cause mortality, and fertility rate (independent variables)
on the following outcomes: population life expectancy, the rate of (65+) / (15-65) years old people, and the % of people between 0 – 15 years. For
example, among men during 1956-1987, an increase of 10 CVD deaths/100,000 people was associated with: 0.31 years increase in Life Expectancy,
0.01 increase in the rate (65+) / (15-65) years old people and a decrease of 0.15 of the % of people between 0-15 years old.
4. DISCUSSION
Greece is an aged country with already half of its population >43 years of age while population projections suggest
that the aging process will continue in the decades to come, due to fertility and mortality dynamics which favour the
increasing of older groups to the detriment of younger ones, but also lead to the reduction of death rates from diseases
such as CVD, especially in the older age-groups [1]. Furthermore, the continued prolongation of the life span observed
over the last decades, acts cumulatively and aggravates the phenomenon of the aging population.
The Greek population has shown a rapid increase of the elderly people percentage while its median age is currently
among the highest in Europe [12]. In 2015, the share of Greeks that had celebrated their 80th birthday (6.3%) was the
second highest in EU, very close behind Italy (6.4%) [12]. Simultaneously, life expectancy increased by almost 4 years
since  the  1990s  (although slower  than other  countries)  and by almost  10 years  since  the  1970s,  a  figure  that  gives
Greece  a  World  Life  Expectancy  ranking  of  25  among  the  WHO countries  [13].  This  phenomenon  does  not  only
characterize the Greek population. The vast majority of modern economies are aging; some of them at a fast pace and
exhibit lowering fertility rates and increases in life expectancy [14, 15]. The combined effect of increased longevity and
low fertility is responsible for a great part of the population “greying”.
Although Greece was among the last countries to join Europe’s declining fertility course, these late though sharp,
falling fertility rates soon reached the lowest levels world-wide. In particular, compared with 1.4 in the 1990s and to
2.20 in the 1980s, in 2015 fertility rate was only 1.3 births/woman, that is far below the value of 2 - which is considered
as the replacement rate for a population resulting in relative stability - and is indicative that population is decreasing in
size  and  growing  older  [16].  According  to  EUROSTAT  [11]  estimates,  by  2030,  the  overall  size  of  the  Greek
population is projected to be smaller, but much older. Although projections are nothing more than projections, based on
assumptions, it is currently beyond any doubt that the greying of the Greek population will impose serious financial and
social burdens [17].
Prima facie, CVD mortality trends herald optimistic news as death rates have been reduced quite substantially in the
last  4  decades,  although  differentiations  have  been  observed  according  to  the  county-region,  the  statistical  method
applied and the source of mortality information [18, 19]. In many European countries, in 2009 death rates from heart
disease  were  <50%  as  compared  with  the  1980s  [1].  Similar  trends  have  been  recorded  for  stroke  and  CHD  in
particular, as expected since they are both a part of the general category of CVD. These declines in CVD mortality have
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been mainly attributed to the progress made in cardiovascular care and to efficient cardiovascular treatment (e.g. use of
statins and better antihypertensive medication) [1], a breakthrough in medical science that was experienced and became
strongly perceptible in Greece from the late ‘80s and onwards [20]. Unfortunately, a second and more insightful look
raises some justifiable concerns: i) the most recent evidence indicates a renewed increase in CVD mortality rates which
seems strongly affected by the undergoing economic crisis,  ii)  CVD remains the leading cause of  death in Greece,
responsible for approximately 5 in every 10 deaths (i.e. 48%; 26% for CHD and 22% for stroke) during 2000-2015,
whereas 90% of those deaths concerned adults above 60 years old [10, 13]. Similarly, 32% of the deaths globally were
attributable to CVD, making it the leading cause of death worldwide [21], iii) the demographic transition is a major
driver  of  CVD; the same time that  death rates  have fallen globally  by 22%, the raw numbers  of  CVD deaths  have
increased by 41% due to the aging and growth of the world’s population [21], iv) substantial differences have been
observed between High-Income (HIC) and Low- and Middle-Income Countries (LMIC); from 1990 to 2013, in HICs a
43% decline in CVD death rates has been seen while no significant changes have been observed in the CVD-related
number of deaths [21]. On the other hand and during the same period, in LMICs, the decrease in CVD mortality rates
was much lower (i.e.  only 13%) while being accompanied by a simultaneous increase of the raw numbers in CVD
deaths by 66% [21], v) during the last decades, evidence of an increase in diabetes and obesity prevalence among adults
has  been  reported  while  in  some  regions  similar  increases  have  been  observed  for  smoking,  physical  inactivity,
dyslipidaemia, hypertension and psychological distress (i.e. CVD risk factors) [1, 3, 4, 22 - 24], vi) it has also been
formulated that the current national trends in CVD mortality have masked local increases, especially among younger
adults (i.e. below 65 years old) [25], vii) it has been hypothesized that the recorded declining CVD mortality rates are
mainly related to the older ages, while the corresponding trends among younger adults seem to be plateauing or even
rising as the increase in the prevalence of obesity and diabetes is cancelling the gains from reducing smoking [1] while,
as far as premature deaths are concerned, CVD is enhanced steadily, beginning at ages as young as 30-34 years, where
it accounted for 11% of all deaths [20], and, viii) notably in Greece, it has been suggested that the recent declining
trends  in  all-cause  mortality  [26]  and  in  CVD  death  rate  particularly,  do  not  necessarily  go  hand  in  hand  with
corresponding morbidity reductions. This is supported by several facts such as: the increasing environmental pollution
that enhances the propagation of adverse pathophysiological processes, linked with atherosclerosis, including genetic,
haemodynamic, metabolic, oxidative and inflammation parameters [27]; the observed deviation from the healthy and
cardioprotective Mediterranean dietary pattern during the past decades [28]; the increment in the key CVD risk factors
that has been discussed earlier; and the phenomenon of population aging and social upheavals clearly suggest that shifts
towards the upper part of the age pyramid entail a reshuffling in the disease prevalence [21].
Population aging is a historically unprecedented event that cannot be avoided, deterred or alleviated. Much of this
demographic phenomenon is attributed to the progress made towards longevity, which is a great achievement. The same
applies  to  the  spectacular  progress  made in  medical  and pharmacological  science with  consequence the  substantial
decrease in mortality rates. Spectacular though this progress may seem, it is not free from negative side effects. In order
to fully exploit these undoubtedly positive steps, for the benefit of society by promoting well-being the side effects
arisen must be efficiently and constructively answered, as longer lifespan does not necessarily mean healthier additional
years.  Life  expectancy  at  65  is  19  years  (for  both  sexes),  while  healthy  life  expectancy  is  only  8  years.  Stated
differently, <42% of the remaining years of a 65-year old Greek are expected to be in good health [29, 30]. An option is
to timely prepare societies for the years to come through the restructuring of the health care system, the review of the
budgetary constraints and the implementation of innovative ideas. A possible way to successfully cope with the new
demographic  realities  is  to  unlock an,  up till  now largely overlooked,  opportunity  named “healthy aging” which is
described by the World Health  Organization as  a  process  of  developing and maintaining the functional  ability  that
enables  well-being  in  older  age  [31].  Functional  ability  is  made  up  of  the  intrinsic  individual’s  ability,  the
environmental characteristics and the interactions between them while well-being theoretically involves the concepts of
satisfaction,  fulfilment  and  happiness  [31].  Longevity  in  good  health  seems  today  the  “comparative  advantage”  of
Europe “vis à vis” all  other aging societies [32].  Europeans in their  sixties and early seventies are more physically
robust, more mentally alert and better educated than ever before [33] but efforts in this direction should be continued
and stepped up so that healthy aging can be achieved for the entire population regardless of societal, economic, racial,
cultural or religious characteristics. The results of the study can be also interpreted using the classic Omran’s theory of
epidemiological transition [34]. Factors involved in the epidemiological transition are demographic changes, biological
factors (microorganisms), environmental factors, social, cultural and behavioural factors and the practices of modern
medicine [35]. The dominant role of SDH (Social Determinants of Health) in population health status has been widely
recognized [36]. In addition, the particular impact of the SDH on CVD, in view of the epidemiological transition, has
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been documented [37] and thus, due to the recent financial crisis in Greece, further study of the impact of the social
conditions on the CVD in the Greek population during the last decade could be considered.
Strengths and limitations: although the present work has documented valuable official data describing mortality and
demographic trends and the association between them over a 60-year period, unfortunately no data was available on
CVD morbidity or on CVD raw death numbers during the same period.
CONCLUSION
In light of the projected growing proportion (and number) of old aged population and under the assumption of no
major changes in either, risk factors or treatment, CVD prevalence is expected to increase in the decades to come in
Greece.  The  burden  of  CVD and  its  cardiometabolic  disorders  is  high,  particularly  in  the  urban  Greek  population,
despite the various strategic plans and public health actions developed in the past years. The aforementioned findings
underlie the need for emerging and focused prevention strategies in order to reduce the CVD burden at population level,
especially in view of the dramatic population aging and the current economic crisis.
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